This bill amends Maine's insurance code to explicitly include the MaineCare program as a "carrier" for prescription drug benefit purposes. The change clarifies that MaineCare, which provides health coverage to low-income residents, is treated similarly to private insurance carriers under state insurance regulations. By adding MaineCare to the definition of carrier, the legislation ensures the program falls under existing insurance code provisions governing prescription drug benefits. This adjustment affects how MaineCare is classified within the state's insurance framework without altering the program's core eligibility or funding structure.
This joint resolution designates March 2026 as Social Work Month in Maine to honor the contributions of social workers to community well-being and social justice. The bill highlights how these professionals support vulnerable populations, advocate for civil rights, and improve access to mental health and educational services. It directs that copies of the resolution be sent to several state universities with social work programs and the Maine chapter of the National Association of Social Workers.
LD 2004 modifies Maine's existing Fund To Address Food Insecurity and Provide Nutrition Incentives to better support local programs. It allows the fund to match private/public contributions up to $50,000 annually, prioritizing Maine-based organizations with experience helping low-income residents use federal food assistance (like SNAP) to buy locally grown fruits and vegetables. The bill requires organizations applying for funds to demonstrate how they will leverage the money or have a history of promoting local food access. It also mandates regular reporting and audits to ensure funds are used appropriately for nutrition incentive programs.
LD 697 directs Maine's Prescription Drug Affordability Board to set annual spending targets for prescription drugs purchased by state and local government health plans (excluding MaineCare), using a formula based on a 10-year average of medical care costs plus inflation, minus savings. The board must assess cost-reduction strategies, including reference-based pricing - which aligns drug prices with those in other regions - and establish a 12-member advisory council with representatives from state agencies, labor unions, and consumer groups to advise on setting targets and methods. The board will also identify public payors (state, county, and municipal health plans) likely to exceed the spending targets.
LD 1738 establishes a grant program to fund community efforts in safely disposing of used hypodermic needles (biohazard waste), directly supporting community organizations (like needle exchange programs) and local health departments. The program provides funding for purchasing disposal containers, hiring staff to collect discarded needles, and running public education campaigns. Grants prioritize projects in areas with rising reports of improperly discarded needles and those using collaborative or innovative approaches. The Maine Center for Disease Control and Prevention will administer the program and submit annual reports to the legislature on outcomes and funding needs.
LD 858 creates a state grant program to help schools access behavioral and mental health services for students. It provides schools with $3,000 to $9,000 annually based on student population (e.g., $9,000 for schools over 500 students) to contract with licensed external providers. The grants cannot cover services already paid for by MaineCare, and funds must supplement - not replace - existing school mental health staff. This program, funded at $1.353 million yearly starting in 2025-26, directly supports school districts in expanding student mental health resources.
LD 163 requires all health insurance plans in Maine covering prescription drugs or outpatient services to fully cover federally approved nonprescription oral hormonal contraceptives and emergency contraceptives without any deductibles, copays, or coinsurance. This applies directly to health insurers and enrollees, eliminating out-of-pocket costs for these specific contraceptives. The bill clarifies that no prescription is needed to obtain these items, and coverage must include supplies for a full 12-month period. It specifically excludes coverage for abortion-inducing drugs. The law updates Maine’s health insurance coverage requirements to align with federal contraceptive approvals.
LD 117 provides $1.23 million in state funding for sexual assault services during the 2025-2026 fiscal year, increasing to $1.83 million for 2026-2027. The funds are allocated through the Department of Health and Human Services' Purchased Social Services program to directly support local sexual assault service providers. This funding covers essential services like crisis counseling, medical advocacy, and legal support for survivors. The bill does not create new programs but ensures sustained financial support for existing services across Maine.
This bill allocates $250,000 from the General Fund for each of the 2025-26 and 2026-27 fiscal years to support Maine's free health clinics. The funding will be distributed by the Department of Health and Human Services using a formula based on the number of clients served at each clinic plus a base amount per clinic. It directly affects community health clinics providing services to low-income residents, particularly in underserved areas. The bill is a one-time funding measure with no new policy requirements, solely providing financial support for existing clinic operations.
LD 93 expands Maine's Universal Childhood Immunization Program to cover all adults residing in the state, not just children under 19. The bill amends existing law to define "individual" as any Maine resident and modifies program administration to include adults in the vaccine coverage. It maintains the same funding mechanism through the Childhood Immunization Fund, requiring assessed entities (like insurance providers) to pay quarterly assessments based on the number of covered residents. This change aims to reduce costs and increase access to recommended vaccines for all age groups by extending the existing childhood program framework.
